Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Fortress Biotech Inc (NQ: FBIO)
1.600 USD  +0.070 (+4.58%)
Official Closing Price  /  Updated: 5:56 PM EDT, Aug 16, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 160,000
Open 1.560
Bid (Size) 1.500 (100)
Ask (Size) 1.650 (3)
Prev. Close 1.530
Today's Range 1.525 - 1.670
52wk Range 0.4900 - 2.590
Shares Outstanding 52,902,146
Dividend Yield N/A
Performance
YTD
+46.79%
+46.79%
1 Month
+26.98%
+26.98%
3 Month
-16.23%
-16.23%
6 Month
-25.58%
-25.58%
1 Year
-16.23%
-16.23%
Top News
More News
Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
from GlobeNewswire News Releases
Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103 in HER2-Positive Breast Cancer with Brain Metastases
City of Hope awarded California Institute for Regenerative Medicine grant to support ongoing Phase 1 clinical trial Read More
from GlobeNewswire News Releases
More News
Read More
Mustang Bio to Present at 11th Annual Bioprocessing Summit
from GlobeNewswire News Releases
Penny Stocks to Watch in August: Stars Group and Fortress Biotech
category hot stocks , good penny stocks , micro stock , and 52 more.
from MicroSmallCap
Penny Stocks to Watch in August: Stars Group and Fortress Biotech
category small cap stocks , FBIO stock , good penny stocks , and 52 more.
from MicroSmallCap
Mustang Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
from GlobeNewswire News Releases
Fortress Biotech Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
from GlobeNewswire News Releases
Checkpoint Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
from GlobeNewswire News Releases
FDA Clears IND for Mustang Bio’s MB-102 (CD123 CAR T)
from GlobeNewswire News Releases
Avenue Therapeutics Announces Appointment of Ms. E. Garrett Ingram to Board of Directors
from GlobeNewswire News Releases
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid Leukemia
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.